Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors.
Kawahara T, Kawai K, Kojima T, Nagumo Y, Sakka S, Kandori S, Negoro H, Mathis BJ, Maruo K, Miura K, Sakamoto N, Shinohara N, Yamashita S, Yonemori K, Kishida T, Ukimura O, Nishimura K, Kobayashi Y, Nishiyama H.
Kawahara T, et al. Among authors: mathis bj.
Int J Urol. 2022 Jul;29(7):741-747. doi: 10.1111/iju.14885. Epub 2022 Apr 23.
Int J Urol. 2022.
PMID: 35462438
Free PMC article.
Clinical Trial.